Paying users zone. Data is covered by .
Get to Regeneron Pharmaceuticals Inc. for $15.99, or
get to entire website for at least 3 months from $49.99.
Enterprise Value (EV)
Current Enterprise Value (EV)
Regeneron Pharmaceuticals Inc., current enterprise value calculation
|Current share price (P)||$|
|No. shares of common stock outstanding|
|USD $ in thousands|
|Common equity (market value)|
|Add: Preferred Stock, $.01 par value; issued and outstanding - none (per books)|
|Add: Capital and facility lease obligations, current portion (per books)|
|Add: Convertible senior notes, current portion (per books)|
|Add: Capital and facility lease obligations, excluding current portion (per books)|
|Add: Convertible senior notes, excluding current portion (per books)|
|Total equity and debt|
|Less: Cash and cash equivalents|
|Less: Marketable securities|
|Enterprise value (EV)|
Based on: 10-K (filing date: 2019-02-07).
Historical Enterprise Value (EV)
Regeneron Pharmaceuticals Inc., EV calculation
1 Data adjusted for splits and stock dividends.
2 Close price on the filing date of Regeneron Pharmaceuticals Inc.’s Annual Report.
|EV||Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments.||Regeneron Pharmaceuticals Inc.’s EV declined from 2016 to 2017 but then increased from 2017 to 2018 exceeding 2016 level.|